drug · small molecule
patient view →omadacycline tosylate
Marketedupdated 2mo agoby Paratek Pharmaceuticals Inc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for skin disease and bacterial pneumonia and 1 investigational indication.
targets
Bacterial 70S ribosome
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that